Beste apotheek van Nederland

Matthew A G, Goldman A, Trachtenberg J et al. Sexual
dysfunction after radical prostatectomy: Prevalence, treatments,
restricted use of treatments and distress. Br J Urol
2005;174(6):2105-2110.
Maytom M C, Derry F A, Dinsmore W W et al. A two-part pilot
study of sildenafil (VIAGRA) in men with erectile dysfunction
caused by spinal cord injury. Spinal Cord. 1999;37(2):110-116.
McCarthy Barry W. Relapse prevention strategies and
techniques with erectile dysfunction. J Sex Marital Ther
2001;27(1):1-8.
McClellan K J, Goa K L. Transdermal testosterone. [Review]
[17 refs]. Drugs 1998;55(2):253-258.
McClure R D. Endocrine evaluation and therapy of erectile
dysfunction. [Review] [77 refs]. Urol Clin North Am
1988;15(1):53-64.
McConnell J D, Roehrborn C G, Bautista O M et al. The Long-
Term Effect of Doxazosin, Finasteride, and Combination
Therapy on the Clinical Progression of Benign Prostatic
Hyperplasia. N Engl J Med 2003;349(25):2387-2398.
McCullough A R, Barada J H, Fawzy A et al. Achieving
treatment optimization with sildenafil citrate (Viagra) in patients
with erectile dysfunction. Urology 2002;60(2 Suppl 2):28-38.
McKinlay J B. The worldwide prevalence and epidemiology of
erectile dysfunction. [Review] [17 refs]. Int J Impot Res
2000;12Suppl-S11.
McMahon C. Comparison of erectile responses to differing
doses of prostaglandin PGE1 in an attempt to standardise
pharmacological diagnosis of impotence. Journal of Assisted
Reproduction & Genetics 1992;9265A
McMahon C G. Nonsurgical treatment of cavernosal venous
leakage. Urology 1997;49(1):97-100.
McMahon C G. Treatment of Erectile Dysfunction with Chronic
Dosing of Tadalafil. Eur Urol 2006;50(2):215-217.
McMahon C G. Priapism associated with concurrent use of
phosphodiesterase inhibitor drugs and intracavernous injection
therapy. Int J Impot Res 2003;15(5):383-384.
McMahon C G, Stuckey B G A, Andersen M et al. Efficacy of
sildenafil citrate (viagra) in men with premature ejaculation. Br J
Sex Med 2005;2(3):368-375.
Mealy N E. NBI-69733. Drugs of the Future 2004;29(6):642
Mealy N E. GPI-1485. Drugs of the Future 2004;29(6):640
Mealy N E. EMR-62203. Drugs of the Future 2004;29(6):639
Mealy N E. Dasantafil. Drugs of the Future 2004;29(6):633
Mealy N E. DA-8159. Drugs of the Future 2004;29(6):631
Mealy N E. Avanafil. Drugs of the Future
2004;29(6):628-629.
Mealy N E. Alprostadil cream. Drugs of the Future
2004;29(6):626-627.
Mealy N E, Bayes M. PT-141. Drugs of the Future
2004;29(11):1177
Mealy N E, Bayes M. ABT-724. Drugs of the Future
2005;30(9):935
Mehdiyev T V. Intracavernous injection probe of
vasoactive preparations in the diagnosis of erectile
dysfunctions in patients with diabetes mellitus.
Azerbaidzhanskii Meditsinskii Zhurnal 2002;(pp 17­
19):-19.
Meinhardt W, Kropman R F, Vermeij P et al. The
influence of medication on erectile function. Int J
Impot Res 1997;9(1):17-26.
Melman A, Bar-Chama N, McCullough A et al. The
first human trial for gene transfer therapy for the
treatment of erectile dysfunction: preliminary results.
Eur Urol 2005;48(2):314-318.
Mendelson W B, Gujavarty K, Slintak C et al.
Reported sexual dysfunction in obstructive sleep
apnea patients. Ann Clin Psychiatry 1990;2(2):93-101.
Merrick G S, Wallner K E, Butler W M. Minimizing
prostate brachytherapy-related morbidity. Urology
2003;62(5):786-792.
Metawea B, El-Nashar A R, Gad-Allah A et al.
Intracavernous papaverine/phentolamine-induced
priapism can be accurately predicted with color
Doppler ultrasonography. Urology 2005;66(4):858­
860.
Meyhoff H H, Rosenkilde P, Bodker A. Non-invasive
management of impotence with transcutaneous
nitroglycerin. Br J Urol 1992;69(1):88-90.
Migliari R, Muscas G, Usai E. Effect of Casodex on
sleep-related erections in patients with advanced
prostate cancer. Br J Urol 1992;148(2 I):338-341.
Mikhail N. Efficacy and safety of sildenafil in patients
with congestive heart failure [7]. Arch Intern Med
2004;164(18):2067-2068.
Millard R J, Stricker P D, Lynch W J et al. Risks of
self-injection therapy for impotence. Med J Aust
1996;165(2):117-118.
Miller D C, Wei J T, Dunn R L et al. Use of
medications or devices for erectile dysfunction among
long-term prostate cancer treatment survivors:
potential influence of sexual motivation and/or
indifference. Urology 2006;68(1):166-171.
D-74